DeBio Network announces their first medical partnership with Genomic YARSI.
DeBio Network has announced their first medical partnership with Genomic YARSI. Genomic YARSI is a genomics research institute based in Jakarta, Indonesia.
Decentralized Bio (DeBio) Network is a technology startup that utilizes cutting-edge blockchain technology for biomedical testing and bioinformatics analysis. It is a privacy-first platform targeted at privacy-conscious users of biomedical services.
Genomic YARSI is a genomics research institute based in Jakarta, Indonesia. It was founded in 2012 and headed by dr. Rika Yuliwulandari, Ph.D. It has received many research grants such as the Indonesian Ministry of Research, Technology and Higher Education decentralization fund, YARSI University internal funding, the National Institute of Health USA, the Genome Institute of Singapore, the Thai Ministry of Public Health, and the Japan Society for the Promotion of Science Core-to-Core Research Programs.
In this collaboration, Genomic YARSI will test the NAT2 gene using the qPCR and Sanger Sequencing methods on DNA samples obtained from volunteers. Polymorphisms in this gene are associated with higher incidences of cancer and drug toxicity.
DeBio Network Launch on Skyward Finance and Whitelisted on Ref Finance
DeBio Network has officially launched their public investment round on Skyward Finance. The public investment round will begin by having a sale on Skyward Finance. Subsequently, Ref Finance has also whitelisted DeBio Network to allow them on Ref’s decentralized exchange.
DeBio Network Enters Booting Stage on Octopus Network
DeBio Network has entered the booting phase in the release pipeline and has gone through most of the stages required before release on the Octopus Network. During the Voting phase when the community pledged USD 1 million to DeBio Network. DeBio Network’s community also came through during the Staging phase pledging another USD 1.96 million.
The DeBio Network team is confident in their IDO, which begins on November 14th, 2021, and will release their app shortly afterward.